IRCT20200506047323N7
Not yet recruiting
Phase 3
Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia admitted to the Intensive Care Unit
Bandare-abbas University of Medical Sciences0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- U07.2
- Sponsor
- Bandare-abbas University of Medical Sciences
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Definitive diagnosis of COVID\-19 based on RT\-PCR or/and serological testing,
- •Age \>20 years.
- •Diagnosis of pneumonia based on pulmonary CT\-Scan.
- •Admitted in the intensive care unit.
- •Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm.
Exclusion Criteria
- •Patients with underlying disorder, including convulsive disorders, hepatic disease and disorder, renal disease and disorder.
- •Intubated patients and use of mechanical ventilation.
- •pregnancy and breastfeeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
The effect of melatonin in Ulcerative colitislcerative colitis.Ulcerative colitisIRCT20121021011192N9Shahid Beheshti University of Medical Sciences40
Recruiting
Phase 2
Melatonin and Covid-19covid-19.COVID-19 DiseaseU07.01IRCT20210505051197N1Rasht University of Medical Sciences96
Recruiting
Phase 3
Evaluation of the effect of melatonin in the treatment of problems caused by androgen deprivation therapy in prostate cancer patientsIRCT20180722040556N5Esfahan University of Medical Sciences66
Recruiting
Phase 3
Protective effect of Melatonin on clinical outcomes in patients with acute ischemic strokeIRCT20231220060484N1Islamic Azad University70
Not yet recruiting
Phase 3
Evaluation of the effect of melatonin on COVID 19IRCT20210411050925N1Iran University of Medical Sciences100